Halofuginone Suppresses Hepcidin by a Heparan Sulfate-dependent Mechanism to Treat Iron Disorders in Mice

By afschroeder • February 12, 2026

Leal S, Denardo A, Van Echten A, Jungnickel H, Nelson CB, Sandoval D, Salvador JA, Shin J, Chung A, Brush M, Bennett CP, Piermatteo A, Secrest P, Jung CL, Ganz T, Poli M, Gordts P. Halofuginone Suppresses Hepcidin by a Heparan Sulfate-dependent Mechanism to Treat Iron Disorders in Mice. Blood Adv. 2026 Feb 11:bloodadvances.2025017943. doi: 10.1182/bloodadvances.2025017943. Epub ahead of print. PMID: 41671472.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Symptom Burden After Dialysis Initiation and Its Association With Hospitalization

Nair D, Cai X, Hays RD, Aiyegbusi OL, Frazier RS, Isakova T, Peipert JD. Symptom Burden After Dialysis Initiation and Its Association With Hospitalization. Kidney[...]

A Case of Thyroid Dermopathy

Day AJ, Sarantopoulos GP. A Case of Thyroid Dermopathy. Cureus. 2026 Jul 29;18(7):e113624. doi: 10.7759/cureus.113624. PMID: 42668724; PMCID: PMC13525185.

Calpeptin Reduces Extracellular Vesicle Secretion and Induces Anti-Inflammatory Effects but Upregulates HO-1 and Alters Adiponectin Levels in Human Adipocytes

Matilainen J, Foster S, Berg V, Tampio J, Turunen T, Mustonen AM, Kyykallio H, Vaittinen M, Männistö V, Pihlajamäki J, Malinen M, Oikari S, Käkelä[...]